These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3234595)

  • 1. Effect of dopamine on plasma growth hormone and prolactin concentrations under anaesthesia.
    Mikawa K; Kusunoki M; Obara H; Iwai S
    J Int Med Res; 1988; 16(6):403-12. PubMed ID: 3234595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.
    Ferrari C; Romussi M; Benco R; Rampini P; Mailland F
    Acta Endocrinol (Copenh); 1983 May; 103(1):1-6. PubMed ID: 6407250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Levels of growth hormone and prolactin in the blood before, during, and after selective transsphenoidal adenectomy in patients with acromegaly and hypophyseal prolactin-producing tumors].
    Sekso M; Vizner B; Reiner Z; Gnjidić Z; Skrablin-Kucić S; Brkić K
    Acta Med Iugosl; 1987; 41(4):229-44. PubMed ID: 3687487
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of treating acromegaly and prolactinoma patients by trans-sphenoid selective adenomectomy].
    Bozadzhieva E; Karag'ozov L; Andreeva M; Kekhaĭov A; Platonova E
    Probl Endokrinol (Mosk); 1985; 31(6):29-32. PubMed ID: 4088986
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of suppressive effect of somatostatin on prolactin levels in patients with hyperprolactinemia.
    Bronstein MD; Knoepfelmacher M; Liberman B; Marino R; Germek OA; Schally AV
    Horm Metab Res; 1987 Jun; 19(6):271-4. PubMed ID: 2887502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
    Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
    Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
    Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
    Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients.
    Verde G; Oppizzi G; Colussi G; Cremascoli G; Botalla L; Müller EE; Silvestrini F; Chiodini PG; Liuzzi A
    Clin Endocrinol (Oxf); 1976 Jul; 5(4):419-23. PubMed ID: 971548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma.
    Grottoli S; Gasco V; Broglio F; Baldelli R; Ragazzoni F; Gallenca F; Mainolfi A; Prodam F; Muccioli G; Ghigo E
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1595-9. PubMed ID: 16449338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
    Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
    Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymulin and zinc circulating levels in patients with GH and PRL secreting pituitary adenomas.
    Travaglini P; Mocchegiani E; Togni ME; Muratori M; Re T; Bazzoni N; Fabris N
    Int J Neurosci; 1990 Apr; 51(3-4):269-71. PubMed ID: 2279883
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma.
    Xia P; Shi YF
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(3):121-5. PubMed ID: 2594732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to bromocriptine in prolactinomas.
    Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
    Primeau V; Raftopoulos C; Maiter D
    Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
    Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
    J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.
    Ikuyama S; Nawata H; Kato K; Ibayashi H; Nakagaki H
    J Clin Endocrinol Metab; 1986 Apr; 62(4):729-33. PubMed ID: 2869049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.